⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMTX News
Immatics N.V. Ordinary Shares
Immatics Announces Third Quarter 2025 Financial Results and Business Update
globenewswire.com
IMTX
Immatics Achieves Clinical Proof-of-Concept of its Next-Generation TCR Bispecific (TCER®) Pipeline with Data on IMA402 (PRAME) and IMA401 (MAGEA4/8) and Announces Next Development Steps
globenewswire.com
IMTX